Research in the ME/CFS field has implicated immune and microbial dysbiosis in ME/CFS patients, so a major goal of our ME/CFS Center at JAX is to deeply characterize patient clinical phenotypes together with immunologic, metabolic, and microbiome markers in the blood and gut.
Over the course of the five year study, we aim to recruit 150 ME/CFS patients and follow them through three time points over the course of three years, where we will collect detailed clinical information, blood, and stool samples.
We also aim to recruit 100 age- and sex-matched healthy controls, and 50 controls will be followed through a second time point.
As we approach the end of second year of the study, we would like to share some of our progress with the ME/CFS community.
